anzUp Nivo->Ipi+Nivo Sequential Non-clear cell – Proposed Phase II Sequential Cohort Trial Of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab In Metastatic Or Unresectable Non-Clear Cell Renal Cell Carcinoma.